ETF Database » PPH

Three ETFs To Watch This Week: PPH, REM, UNG

Jared Cummans — Mon, 30 Jan 2012 09:00:20 +0000

The past few weeks have seen a nice rally to start off the new year. With a number of encouraging earnings and data reports, stocks have been on a tear, with the S&P hitting 1,300 for the first time in several months. But last Friday’s GDP report, though representing strong growth, may have adverse effects on the recent rally. ”[GDP] was still a nice number, but short of expectations, and I think that that’s contributing to some of the market’s weakness,” said Thomas Wilson, senior investment manager at Brinker Capital. The coming week will try and shake off the lower than expected GDP with earnings from more bellwether U.S. firms. Below, we outline three ETFs to keep a close eye on as the week unfolds [see also The Ten Commandments of Commodity Investing]. Market Vectors Pharmaceutical ETF (PPH) Why PPH Will Be In Focus: This ETF was recently converted from its [...]

Click here to read the original article on ETFdb.com.

10 Equity ETFs That Surged In 2011 (And Might Do The Same In 2012)

Michael Johnston — Tue, 27 Dec 2011 12:00:27 +0000

This time last year, investors were generally thrilled with the performances of their portfolios, which had continued to bounce back nicely from the devastating recession that hit in 2008. Unfortunately, few are feeling the same sense of accomplishment as 2011 draws to a close; this year has been frustrating in that a few large, swift sell-offs erased any gains that had accumulated, leaving many risky asset classes in negative territory for the year [see also Checking In: Top 5 Equity ETFs of 2010]. Continued concerns about the fiscal health of Europe have weighted on markets around the globe, demonstrating once again just how intertwined global markets are and how struggles in one corner of the globe can translate into difficulties elsewhere. Through December 20, the S&P 500 SPDR (SPY) had managed to squeeze out a small gain on the year–which was considerably better than popular international equity ETFs. Emerging markets, [...]

Click here to read the original article on ETFdb.com.

HOLDRS Conversion Begins: Investor Action Required

Michael Johnston — Mon, 14 Nov 2011 11:00:28 +0000

Van Eck has begun the process of converting six HOLDRS products offered by Merrill Lynch into traditional ETFs that will be included under the Market Vectors lineup, offering investors an opportunity to exchange their receipts in HOLDRS trusts for shares in the new ETFs. The exchange requires affirmative action on the part of investors, meaning that advisors or individuals with positions in existing HOLDRS must take action in order to receive shares in the new ETFs. The exchange offer is expected to remain open until December 20. “We have structured the offers, in our view, to be investor friendly,” said Adam Phillips, Managing Director of ETFs at Van Eck Global. “Potential benefits of participation include the opportunity for uninterrupted exposure to target industries, a partially tax-advantaged exchange, and no costs associated with the offers.” Van Eck also noted that the new structure could allow investors to achieve more complete and [...]

Click here to read the original article on ETFdb.com.

New Pharma ETN (DRGS) Hits The Market

Michael Johnston — Tue, 25 Oct 2011 13:30:38 +0000

RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (DRGS) will seek to replicate the NYSE Arca Equal Weighted Pharmaceutical Total Return Index, a benchmark that consists of equal allocations to about 16 different companies involved in various phases of development, production and marketing of pharmaceuticals. Under The Hood Half of the underlying portfolio consists of U.S. companies, with the other 50% of the index split between the UK (3 companies), Switzerland, Denmark, France, Israel, and Canada (one company each). The components are equal-weighted, meaning that the allocation to each is approximately equivalent upon rebalancing. Equal-weighted indexes have become increasingly popular as the underlying for exchange-traded products, as many investors have embraced this methodology as an alternative to the potentially inefficient–but still dominant–market capitalization weighting. Because equal weighting breaks the link between index [...]

Click here to read the original article on ETFdb.com.

The Pharma Four: Similar ETFs, Different Returns

Jared Cummans — Mon, 17 Oct 2011 13:45:33 +0000

Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain access to this investment class. But with the four products being very similar, it can be difficult to pick and choose one ETF over the other. While underlying holdings or investment strategies may be similar, the returns of these products has been drastically different over the last few years, which may swing investors one way or the other on these ETFs [see also Three Things Wall Street Journal Didn’t Tell You About Commodities]. HOLDRS Merrill Lynch Pharmaceutical (PPH) This HOLDRS fund debuted in 2000 and is an investor favorite, with nearly $500 million in assets and an average daily volume well over 300,000. [...]

Click here to read the original article on ETFdb.com.

ETF Shakeup: HOLDRS Headed For Extinction, ELEMENTS To Follow?

Michael Johnston — Wed, 24 Aug 2011 11:00:52 +0000

The competitive landscape of the ETF industry has evolved rapidly over the last several years, with several new players–both big and small–making a push into the space. From financial giants such as RBS and Citi to relative unknowns such as Javelin and Precidian, the roster of active ETF issuers has grown to nearly four dozen. Now, mirroring a trend playing out in the lineup of exchange-traded products, it appears that some contraction is in order. Coming months could see a few ETP issuers wiped off the map, as a series of fund closures and mergers should reduce the number of companies that market exchange-traded products [see also ETF Update: Pipeline Continues To Fill]. HOLDRS Winding Down Earlier this month, Van Eck and Merrill Lynch announced a unique arrangement that would convert six of the most popular HOLDRS products into more traditional Market Vectors ETFs. While HOLRDS are often grouped under [...]

Click here to read the original article on ETFdb.com.

Van Eck, Merrill Partner: Conversion of HOLDRS Ahead?

Michael Johnston — Mon, 15 Aug 2011 11:00:51 +0000

Van Eck announced last week a partnership with Merrill Lynch that may ultimately lead to the conversion of several HOLDRS products to soon-to-be-launched Market Vectors ETFs. As part of the agreement, Van Eck will introduce six new ETFs that maintain the same tickers as the existing HOLDRS but that will be part of the Market Vectors family of ETFs. Van Eck said it expects the exchange to be launched in the third quarter of this year and consummated in the fourth quarter. The agreement would cover six existing HOLDRS, which would be converted to Van Eck ETFs that seek to replicate Market Vectors indices. The impacted products include: Ticker New Market Vectors ETF Underlying Index OIH Oil Services ETF Market Vectors US Listed Oil Services 25 Index SMH Semiconductor ETF Market Vectors US Listed Semiconductor 25 Index PPH Pharmaceutical ETF Market Vectors US Listed Pharmaceutical 25 Index BBH Biotech ETF [...]

Click here to read the original article on ETFdb.com.

Tuesday’s ETF To Watch: Pharmaceutical HOLDR (PPH)

Jared Cummans — Tue, 02 Aug 2011 08:00:15 +0000

The past few weeks have been focused on one of the biggest debt crises in U.S. history, as lawmakers sought to find a way through a $14.3 trillion pile of debt. While major equities have suffered their worst stretch in over a year, this quarter’s earnings season has taken a back seat to the debt drama, as numerous bellwethers have seemingly reported under the radar. Typically, earnings season takes the reins of the market for a few weeks once a quarter, as the performance and outlook of multinational firms is often a telling sign of individual industries as well as the economy overall. While the debt ceiling may be making all of the headlines, it is still important for investors to focus on the earnings reports from some of these industry leaders, to get a sense for how the latter half of 2011 will play out [see also ETF Insider: [...]

Click here to read the original article on ETFdb.com.

ETF Insider: Equities Poised To Pop

Stoyan Bojinov — Mon, 01 Aug 2011 13:42:51 +0000

Investors went along for a downhill ride last week as debt woes plagued Wall Street, sending the S&P 500 lower by nearly 4% for the week. Corporate earnings were mostly surprises to the upside, but equities failed to stage a meaningful comeback since investors were more concerned with the debt ceiling drama at home. As expected, gold continued its march higher, with futures prices hitting an all-time high of $1,637 an ounce on Friday morning. Our trade recommendations for this week include a defensive position in a domestic sector fund as well as an international fixed-income ETF, while our bullish pick stands to benefit from a rebound in foreign equities. Weekly Outlook The coming week is stacked with central bank meetings around the globe, including a key interest rate decision by the European Central Bank which will be watched by many given the deteriorating financial health of the Euro zone. [...]

Click here to read the original article on ETFdb.com.

Three ETFs To Watch This Week: IYW, PPH, TLT

Michael Johnston — Mon, 18 Jul 2011 08:00:31 +0000

The beginning of earnings season last week provided a welcome distraction from the more troubling forums that have been capturing the attention of investors in recent weeks. The latest developments in Europe’s ongoing debt saga and twists and turns in Washington related to the fast-approaching debt ceiling have been steering markets in recent sessions. Those events will no doubt continue to influence asset prices this week, but investors will also have a slew of earnings reports from industry bellwethers to consider as well. But the slew of bellwethers reporting earnings this week should provide additional consideration for investors still trying to evaluate the status of the U.S. recovery. The earnings reports form last week were generally positive, highlighted by Google’s impressive second quarter results. The search engine giant jumped more than 12% in after hours trading on Thursday after beating analyst expectations, reclaiming part of the spotlight from smaller tech [...]

Click here to read the original article on ETFdb.com.

ETF Database » PPH

Three ETFs To Watch This Week: PPH, REM, UNG

Related Posts:

10 Equity ETFs That Surged In 2011 (And Might Do The Same In 2012)

Related Posts:

HOLDRS Conversion Begins: Investor Action Required

Related Posts:

New Pharma ETN (DRGS) Hits The Market

Related Posts:

The Pharma Four: Similar ETFs, Different Returns

Related Posts:

ETF Shakeup: HOLDRS Headed For Extinction, ELEMENTS To Follow?

Related Posts:

Van Eck, Merrill Partner: Conversion of HOLDRS Ahead?

Related Posts:

Tuesday’s ETF To Watch: Pharmaceutical HOLDR (PPH)

Related Posts:

ETF Insider: Equities Poised To Pop

Related Posts:

Three ETFs To Watch This Week: IYW, PPH, TLT

Related Posts: